VERAXA Biotech (NASDAQ: VRXA) announced an expansion of its intellectual property portfolio, filing new patent applications during the first half of 2026 covering its next-generation BiTAC-TCE and BiTAC-ADC technology platforms and related therapeutic programs. The company said previously granted patents protecting supporting technologies have also cleared the opposition period, bringing its portfolio to more than […]

Greenland Mines (NASDAQ: GRML) announced that Innovation, Science and Economic Development Canada has granted a patent covering technology exclusively licensed by the company for Klotho-based gene therapies targeting cognition, memory and neurodegenerative diseases. The patent protects the use of the secreted Klotho (“s-KL”) RNA splice variant in genetic therapies and includes 42 claims covering its synthesis, delivery methods and potential […]

Cartilage Regeneration Gains Strategic Validation The orthopedic industry is increasingly focused on technologies that can address cartilage damage by promoting tissue regeneration rather than simply managing symptoms. This opportunity gained additional validation when Smith+Nephew completed its acquisition of CartiHeal, a developer of cartilage repair technology, in a transaction valued at up to $330 million. The acquisition demonstrated […]

MindWave Innovations (NYSE American: APUS), a wholly owned subsidiary of Apimeds Pharmaceuticals, announced MindChain, which it describes as the world’s first fully insured blockchain. The Ethereum Virtual Machine-compatible Layer 2 network is scheduled to launch in October 2026 and is designed to provide Ethereum-backed settlement while supporting faster transactions, staking, cross-chain asset transfers and industry-specific subnetworks. The company also announced that […]

Safe Pro Group (NASDAQ: SPAI) announced it will host its Innovation Day on Aug. 25, 2026, in Aventura, Florida, where the company will showcase its AI-enabled defense and situational awareness technologies through live drone operations and corporate presentations. The event is scheduled to begin at approximately 8:30 a.m. ET and conclude by 12:30 p.m. ET. […]

Safe Pro Group (NASDAQ: SPAI) has released its “Innovation Day Technology Illustration Teaser” video, showcasing the company’s AI-powered ecosystem of computer vision software and mapping tools for drone-based threat detection. The video demonstrates how Safe Pro’s patented “SpotD” technology leverages AI and machine learning trained on one of the world’s largest real-world drone imagery datasets […]

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on advancing innovative therapies and technologies, was featured in a recent episode of the BioMedWire Podcast. During the program, Executive Co-Chairman and Co-Founder Anthony Durkacz discussed the company’s strategy for advancing Lucid-MS, its […]

Datavault AI (NASDAQ: DVLT) announced progress on its NIL debit card capability through its embedded banking and payments arrangement with Fiserv while appointing Ronald M. Goldstein to lead professional sports licensing for its NIL Vault (“NILv”) platform. The company said the planned payment wallets and debit cards are intended to enable participating athletes to receive, manage […]

Datavault AI (NASDAQ: DVLT) announced that former Major League Baseball pitcher Dwight “Doc” Gooden has signed as a brand ambassador for Datavault NILX, the company’s name, image and likeness (“NIL”) exchange platform. Under the agreement, Gooden will produce at least 10 original videos, participate in promotional activities and receive a share of revenue generated by his content, while Datavault AI will provide platform support, activity tracking, attribution and payment administration. […]

VERAXA Biotech (NASDAQ: VRXA) announced that shareholders overwhelmingly approved all proposals presented at its Extraordinary General Meeting, with more than 99.94% of votes cast in favor and 72.20% of the company’s outstanding share capital represented. The approved measures include the introduction of conditional share capital for shareholder options and warrants, implementation of a capital band through Dec. 31, 2030 and […]

VERAXA Biotech (NASDAQ: VRXA) announced the advancement of its bispecific antibody-drug conjugate (“bsADC”) program, VXA-222, after reaching a key technical milestone in its collaboration with OmniAb (NASDAQ: OABI). The company said OmniAb has successfully completed its discovery work, allowing the program to move into its next phase. VXA-222 is designed to target two tumor antigens with a single molecule using […]

A Widening Market for Response-to-Resistance Technology High-profile use-of-force incidents have driven costly litigation, strained community trust, and increased scrutiny of how officers are equipped and trained. That environment has pushed agencies toward tools that create time, distance, and tactical advantage, particularly in encounters involving individuals in mental- or behavioral-health crises and has widened the customer […]